26th International Conference on Optical Fiber Sensors,
Год журнала:
2023,
Номер
unknown, С. Th5.1 - Th5.1
Опубликована: Янв. 1, 2023
The
paper
provides
an
overall
picture
of
the
technological
roadmap
aimed
to
develop
Lab
on
fiber
(LOF)
assisted
needles
for
in-vivo
liquid
and
tissue
biopsy
support
light
localized
therapies
precision
medicine.
Saudi Pharmaceutical Journal,
Год журнала:
2024,
Номер
32(5), С. 102064 - 102064
Опубликована: Апрель 7, 2024
Hepatocellular
carcinoma
(HCC)
exhibits
high
mortality
rates
in
the
advanced
stage
(>90
%).
Sorafenib
(SORA)
is
a
targeted
therapy
approved
for
treatment
of
HCC;
however,
reported
response
rate
to
such
therapeutic
suboptimal
(<3%).
Piperine
(PIP)
an
alkaloid
demonstrated
exert
direct
tumoricidal
activity
HCC
and
improve
pharmacokinetic
profiles
anticancer
drugs
including
SORA.
In
this
study,
we
developed
strategy
efficacy
outcomes
using
PIP
as
add-on
support
first-line
SORA
biodegradable
Poly
(D,
L-Lactide-co-glycolide,
PLGA)
nanoparticles
(NPs).
(both
exhibit
low
aqueous
solubility)
were
co-loaded
into
PLGA
NPs
(PNPs)
stabilized
with
various
concentrations
polyvinyl
alcohol
(PVA).
The
PIP-loaded
PNPs
(SP-PNPs)
characterized
Fourier
Transform
Infrared
(FTIR)
Spectroscopy,
X-ray
Powder
Diffraction
(XRD),
Dynamic
Light
Scattering
(DLS),
Scanning
Electron
Microscopy
(SEM),
Release
these
from
SP-PNPs
was
investigated
vitro
at
both
physiological
acidic
pH,
kinetic
models
employed
assess
mechanism
drug
release.
against
cells
(HepG2)
also
evaluated.
FTIR
XRD
analyses
revealed
that
encapsulated
amorphous
state,
no
observed
chemical
interactions
among
or
excipients.
Assessment
release
pH
5
7.4
showed
loaded
0.5
%
PVA
released
sustained
manner,
unlike
pure
drugs,
which
exhibited
relatively
fast
spherical,
had
average
size
224
nm,
encapsulation
efficiency
(SORA
∼
82
%,
79
%),
well
superior
cytotoxicity
compared
monotherapy
vitro.
These
results
suggest
combining
may
be
effective
set
comprehensive
vivo
study
evaluate
safety
novel
formulation
murine
model.
Advanced Healthcare Materials,
Год журнала:
2024,
Номер
unknown
Опубликована: Май 13, 2024
Current
research
in
cancer
therapy
focuses
on
personalized
therapies,
through
nanotechnology-based
targeted
drug
delivery
systems.
Particularly,
controlled
release
with
nanoparticles
(NPs)
can
be
designed
to
safely
transport
various
active
agents,
optimizing
specific
organs
and
tumors,
minimizing
side
effects.
The
use
of
microfluidics
(MFs)
this
field
has
stood
out
against
conventional
methods
by
allowing
precise
control
over
parameters
like
size,
structure,
composition,
mechanical/biological
properties
nanoscale
carriers.
This
review
compiles
applications
the
production
core-shell
NPs
(CSNPs)
for
therapy,
discussing
versatility
inherent
microchannel
and/or
micromixer
setups
showcasing
how
these
utilized
individually
or
combination,
as
well
technology
allows
development
new
advances
more
efficient
fabrication
nanoformulations.
Recent
biological
studies
have
achieved
an
effective,
safe,
otherwise
unreliable
encapsulants
such
small
interfering
RNA
(siRNA),
plasmid
DNA
(pDNA),
cisplatin
a
result
precisely
tuned
nanocarriers,
showing
that
is
paving
way
innovative
strategies
nanofabrication,
characterized
continuous
high
reproducibility.
Finally,
analyzes
technical,
biological,
technological
limitations
currently
prevent
from
becoming
standard.
Frontiers in Pharmacology,
Год журнала:
2025,
Номер
16
Опубликована: Янв. 24, 2025
The
liver
performs
crucial
roles
in
energy
metabolism,
detoxification,
and
immune
regulation.
Hepatic
diseases,
including
hepatitis,
fibrosis,
cancer,
have
posed
a
significant
threat
to
global
health,
emphasizing
the
critical
need
for
development
of
novel
effective
treatment
approaches.
Nanotechnology,
an
emerging
technology,
has
been
extensively
researched
medicine.
Among
many
types
nanomaterials,
polymeric
nanoparticles
(NPs)
are
widely
used
drug
delivery
systems.
Compared
traditional
therapies,
they
offer
advantages
disease
by
improving
outcomes
reducing
side
effects.
This
review
introduced
discussed
application
natural
polymers
synthetic
their
management.
Furthermore,
this
paper
reviewed
-mainly
chitosan
(CS),
hyaluronic
acid
(HA),
polyethylene
glycol
(PEG)
poly
(lactic-co-glycolic
acid)
(PLGA)-in
treatment,
focusing
on
use
various
systems
pure
bioactive
compounds
origin,
drugs,
nucleic
acids,
peptides,
others.
Finally,
challenges
future
perspectives
NPs
were
provide
guidance
further
research
directions,
with
aim
promoting
clinical
nanotherapeutics
treating
hepatic
diseases.
Biomedicine & Pharmacotherapy,
Год журнала:
2024,
Номер
177, С. 117118 - 117118
Опубликована: Июль 14, 2024
Hepatocellular
carcinoma
(HCC)
is
one
of
the
most
prevalent
malignant
tumors
in
contemporary
era,
representing
a
significant
global
health
concern.
Early
HCC
patients
have
mild
symptoms
or
are
asymptomatic,
which
promotes
onset
and
progression
disease.
Moreover,
advanced
insensitive
to
chemotherapy,
making
traditional
clinical
treatment
unable
block
cancer
development.
Sorafenib
(SFB)
first-line
targeted
drug
for
with
anti-angiogenesis
anti-tumor
cell
proliferation
effects.
However,
efficacy
SFB
constrained
by
its
off-target
distribution,
rapid
metabolism,
multi-drug
resistance.
In
recent
years,
nanoparticles
based
on
variety
materials
been
demonstrated
enhance
targeting
therapeutic
against
HCC.
Concurrently,
advent
joint
delivery
systems
has
furnished
crucial
empirical
evidence
reversing
This
review
will
summarize
application
nanotechnology
field
over
past
five
years.
It
focus
research
progress
combined
multiple
modalities
treatment.
ACS Biomaterials Science & Engineering,
Год журнала:
2024,
Номер
10(7), С. 4336 - 4346
Опубликована: Июнь 8, 2024
Prostate
cancer
(PCa)
with
a
high
incidence
worldwide
is
serious
threat
to
men's
health.
Despite
the
continuous
development
of
treatment
strategies
for
PCa
in
recent
years,
long-term
prognosis
patients
still
poor.
Hence,
discovery
and
novel,
secure,
efficient
therapeutic
approaches
hold
significant
clinical
significance.
Although
sorafenib
(SOR)
displays
potential
as
option
PCa,
its
efficacy
hindered
by
drug
resistance,
limited
water
solubility,
rapid
metabolism.
Therefore,
we
proposed
prepare
nanoparticles
(named
SOR@8P4
NPs)
utilizing
phenylalanine-based
poly(ester
amide)
polymer
(8P4)
carrier
enhance
solubility
stability
SOR
improve
targeting
bioavailability.
NPs
had
showed
acid-responsive
release
at
acidic
tumor
microenvironment.
Additionally,
demonstrated
more
remarkable
anticancer,
antimetastatic,
antiproliferative
abilities
vitro,
compared
those
free
drugs.
significantly
inhibited
growth
vivo.
In
summary,
delivery
system
provides
new
ideas
PCa.
Journal of Hepatocellular Carcinoma,
Год журнала:
2024,
Номер
Volume 11, С. 1265 - 1278
Опубликована: Июль 1, 2024
Abstract:
Ferroptosis
is
a
type
of
cell
death
that
relies
on
iron
and
distinguished
by
the
occurrence
lipid
peroxidation
buildup
reactive
oxygen
species.
has
been
demonstrated
to
have
significant
impact
advancement
resistance
treatment
hepatocellular
carcinoma
(HCC),
thereby
highlighting
its
potential
as
viable
therapeutic
target.
was
observed
in
HCC
tissues
contrast
normal
liver
tissue.
The
inhibition
ferroptosis
found
increase
viability
cells
decrease
their
susceptibility
various
anticancer
therapies,
including
chemotherapy,
radiotherapy,
immune
checkpoint
blockade.
administration
drugs
directly
modulate
regulators
or
induce
excessive
production
lipid-reactive
species
enhance
responsiveness
drug-resistant
treatment.
However,
precise
mechanism
underlying
this
phenomenon
remains
ambiguous.
This
review
presents
comprehensive
overview
crucial
role
played
enhancing
efficacy
for
(HCC).
main
aim
study
examine
feasibility
utilizing
approach
improve
overcome
drug
resistance.
Keywords:
ferroptosis,
carcinoma,
tyrosine
kinase
inhibitor,
immunosuppressive
therapy,
radiotherapy
Frontiers in Pharmacology,
Год журнала:
2025,
Номер
16
Опубликована: Фев. 26, 2025
Nanomedicine
has
received
much
attention
for
its
potential
applications
in
the
diagnosis
and
treatment
of
liver
cancer.
However,
no
bibliometric
evaluation
been
conducted
to
present
an
assessment
scientific
progress
field.
The
aim
this
study
is
comprehensively
catalog
cooperation
influence
journals,
countries,
institutions,
authors
field
nanomedicine
cancer
from
perspective
bibliometrics,
evaluate
clustering
evolution
knowledge
structure,
uncover
hot
topics
emerging
themes.
Articles
reviews
related
were
retrieved
Web
Science
Core
Literature
Library
using
Topic
Search.
#1
T=
("Hepatic
Neoplasm*"
OR
"Liver
Neoplasm"
Cancer*"
"Hepatocellular
"Hepatic
Cancer*"),
#2
"nano*",
search
strategy
set
as
AND
limited
Citation
Index
Expanded
database
source,
with
limitation
publication
types
language/time.
Bibliometric
studies
CiteSpace
VOSviewer.
2,648
articles
included
2000
2024.
number
regarding
showed
increasing
trend.
Analysis
most
productive
journals
shows
that
are
specialized
nanoscience
nanotechnology,
pharmacology
pharmacy,
chemistry
multidisciplinary.
These
publications
mainly
come
8,782
institutions
297
countries
led
by
China
United
States
America.
Shao
D
published
papers
among
publications,
while
Jemal
A
had
co-citations.
macroscopical
sketch
micro-representation
whole
realized
through
co-citation
analysis.
Hepatocellular
carcinoma,
targeted
delivery,
sorafenib
nanoparticles,
others
current
developing
areas
study.
keywords
"nanocrystals,"
"biodistribution,"
"particles"
also
may
be
focus
new
trends
future
research.
In
study,
bibliometrics
visual
methods
used
review
research
comprehensively.
article
will
help
scholars
gain
a
better
understanding
dynamic
point
directions